Medirom Healthcare Technologies (MRM) said Monday that NFES Technologies agreed to be the lead investor in Medirom Mother Labs' series A financing round.
NFES Technologies' participation in the financing round, which values Mother Labs at 9 billion yen ($62.5 million) on a pre-money basis, is expected to attract additional investors, Medirom said.
The company said NFES Technologies will get the series A shares as a third-party allotment.
Shares of Medirom soared more than 178% in premarket activity Monday.
Price: 6.9100, Change: +4.43, Percent Change: +178.63
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。